Evidence map›Paper›PMID 36421281›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Longitudinal Study of Therapeutic Adherence in a Cystic Fibrosis Unit: Identifying Potential Factors Associated with Medication Possession Ratio.

Rosa Mª Girón, Adrián Peláez, Amparo Ibáñez, Elisa Martínez-Besteiro, Rosa Mar Gómez-Punter, Adrián Martínez-Vergara, Julio Ancochea, Alberto Morell

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rosa Mª GirónServicio de Neumología, Instituto de Investigación Sanitaria de La Princesa, Diego de León nº62, 28006 Madrid, Spain.ORCID 0000-0001-7094-0848
Adrián PeláezServicio de Neumología, Instituto de Investigación Sanitaria de La Princesa, Diego de León nº62, 28006 Madrid, Spain.ORCID 0000-0003-0284-6643
Amparo IbáñezServicio de Farmacia Hospitalaria, Hospital Universitario de La Princesa, 28006 Madrid, Spain.
Elisa Martínez-BesteiroServicio de Neumología, Instituto de Investigación Sanitaria de La Princesa, Diego de León nº62, 28006 Madrid, Spain.ORCID 0000-0002-2968-1271
Rosa Mar Gómez-PunterServicio de Neumología, Instituto de Investigación Sanitaria de La Princesa, Diego de León nº62, 28006 Madrid, Spain.ORCID 0000-0003-2484-5908
Adrián Martínez-VergaraServicio de Neumología, Instituto de Investigación Sanitaria de La Princesa, Diego de León nº62, 28006 Madrid, Spain.ORCID 0000-0002-7379-8848
Julio AncocheaServicio de Neumología, Instituto de Investigación Sanitaria de La Princesa, Diego de León nº62, 28006 Madrid, Spain.
Alberto MorellServicio de Farmacia Hospitalaria, Hospital Universitario de La Princesa, 28006 Madrid, Spain.ORCID 0000-0003-4937-4292

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic fibrosis (CF) is a genetic and multisystemic disease that requires a high therapeutic demand for its control. The aim of this study was to assess therapeutic adherence (TA) to different treatments to study possible clinical consequences and clinical factors influencing adherence. This is an ambispective observational study of 57 patients aged over 18 years with a diagnosis of CF. The assessment of TA was calculated using the Medication Possession Ratio (MPR) index. These data were related to exacerbations and the rate of decline in FEV

Indexed as

antibioticsCFTR modulatorscystic fibrosismachine learningMPRrandom foresttherapeutic adherence

Identifiers

PMID36421281
PMCPMC9687051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.